Intra Cellular Therapies | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 0 0 2025-03
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Cytokinetics USD 645.17M 429K 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
Halozyme Therapeutics USD 1.51B 1.65M 2025-03
J&J USD 38.36B 7.7B 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Prothena USD 0 0 2024-12
RedHill Biopharma USD 190K 0 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12
United Therapeutics USD 0 0 2025-03



Intra Cellular Therapies Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.